PTN Earnings

PTN reported its earnings on 2025-11-13, showcasing a revenue of 8.88M against an estimate of , resulting in a 0% surprise. The EPS was 4.26, surpassing the expected 0 by 0%. The stock experienced a -2.17% price change on the earnings day and a 22.78% change over the next five days, reflecting market reactions to the results.

Following PTN's earnings announcement on 2025-11-13, the stock price moved by -2.17% on the day of the release. Over the subsequent five days, it saw a 22.78% change. Historically, PTN's stock price tends to shift by an average of 10.62% in the 10 days leading up to earnings and 2.69% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate PTN's annual revenue to reach 16.67K, while the EPS is projected at -2.26. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between PTN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, PTN's stock price typically moves by 10.62% in the 10 days before its earnings and 2.69% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of -2.26 and revenue of 16.67K.

The earnings call highlights significant progress in product development, with promising next-generation compounds and a strong focus on differentiation, which is positively viewed by analysts. The financial performance shows reduced losses and a strong cash position, supporting future growth. The Q&A reveals confidence in the pipeline's potential and strategic prioritization. Despite some uncertainties in timelines and preclinical outcomes, the overall sentiment is positive, suggesting a likely stock price increase of 2% to 8% over the next two weeks.